[1] Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73: 17-48. [2] Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: A review[J]. JAMA, 2022, 327: 464-477. [3] Blimark C, Holmberg E, Mellqvist UH, et al. Multiple myeloma and infections: A population-based study on 9253 multiple myeloma patients[J]. Haematologica, 2015, 100: 107-113. [4] Raje NS, Anaissie E, Kumar SK, et al. Consensus guidelines and recommendations for infection prevention in multiple myeloma: A report from the International Myeloma Working Group[J]. Lancet Haematol, 2022, 9: e143-e161. [5] Ludwig H, Meckl A, Engelhardt M. Compliance with vaccination recommendations among patients with multiple myeloma: A real world experience[J]. HemaSphere, 2021, 5: e597.doi:10.1097/HS9.0000000000000597. [6] Langerbeins P, Hallek M. COVID-19 in patients with hematologic malignancy[J]. Blood, 2022, 140: 236-252. [7] Ludwig H, Sonneveld P, Facon T, et al. COVID-19 vaccination in patients with multiple myeloma: A consensus of the European Myeloma Network[J]. Lancet Haematol, 2021, 8: e934-e946. [8] Lercher A, Cheong JG, Bale MJ, et al. Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease[J]. Immunity, 2024, 57: 2530-2546.e13. [9] Sun Q, Shan G, Wang W, et al. Reversing hypoxia-induced immune evasion in tumors to enhance cancer immunotherapy[J]. J Control Release, 2025, 382: 113745.doi:10.1016/j.jconrel.2025.113745. [10] Skopelja-Gardner S, An J, Elkon KB, et al. Role of the cGAS-STING pathway in systemic and organ-specific diseases[J]. Nat Rev Nephrol, 2022, 18: 558-572. [11] Jin X, Wang W, Zhao X, et al. The battle between the innate immune cGAS-STING signaling pathway and human herpesvirus infection[J]. Front Immunol, 2023, 14: 1235590.doi:10.3389/fimmu.2023.1235590. [12] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nat Immunol, 2010, 11: 373-384. [13] Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte[J]. Cell, 2005, 123: 321-334. [14] Lan YY, Londoño D, Bouley R et al. Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy[J]. Cell reports, 2014, 9: 180-192. [15] Barber GN. STING: infection, inflammation and cancer[J]. Nat Rev Immunol, 2015, 15: 760-770. |